JP2009529868A5 - - Google Patents

Download PDF

Info

Publication number
JP2009529868A5
JP2009529868A5 JP2008558940A JP2008558940A JP2009529868A5 JP 2009529868 A5 JP2009529868 A5 JP 2009529868A5 JP 2008558940 A JP2008558940 A JP 2008558940A JP 2008558940 A JP2008558940 A JP 2008558940A JP 2009529868 A5 JP2009529868 A5 JP 2009529868A5
Authority
JP
Japan
Prior art keywords
fragment
seq
strain
polynucleotide
mutation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008558940A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009529868A (ja
JP5923232B2 (ja
Filing date
Publication date
Priority claimed from CA002538898A external-priority patent/CA2538898A1/fr
Priority claimed from CA 2545597 external-priority patent/CA2545597A1/en
Application filed filed Critical
Publication of JP2009529868A publication Critical patent/JP2009529868A/ja
Publication of JP2009529868A5 publication Critical patent/JP2009529868A5/ja
Application granted granted Critical
Publication of JP5923232B2 publication Critical patent/JP5923232B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008558940A 2006-03-15 2007-03-15 チクングンヤウイルスの新規な分離されかつ精製された株、並びにそのポリヌクレオチド及びポリペプチド配列、診断及び免疫原性の使用 Expired - Fee Related JP5923232B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CA2,538,898 2006-03-15
CA002538898A CA2538898A1 (fr) 2006-03-15 2006-03-15 Nouvelles souches isolees et purifiees du virus chikungunya et sequences nucleotidiques et peptidiques, applications diagnostiques et immunogeniques
CA 2545597 CA2545597A1 (en) 2006-03-15 2006-04-04 Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof
CA2,545,597 2006-04-04
PCT/IB2007/001716 WO2007105111A2 (en) 2006-03-15 2007-03-15 Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012266306A Division JP6104584B2 (ja) 2006-03-15 2012-12-05 チクングンヤウイルスの新規な分離されかつ精製された株、並びにそのポリヌクレオチド及びポリペプチド配列、診断及び免疫原性の使用

Publications (3)

Publication Number Publication Date
JP2009529868A JP2009529868A (ja) 2009-08-27
JP2009529868A5 true JP2009529868A5 (https=) 2010-04-08
JP5923232B2 JP5923232B2 (ja) 2016-05-24

Family

ID=38481184

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008558940A Expired - Fee Related JP5923232B2 (ja) 2006-03-15 2007-03-15 チクングンヤウイルスの新規な分離されかつ精製された株、並びにそのポリヌクレオチド及びポリペプチド配列、診断及び免疫原性の使用
JP2012266306A Expired - Fee Related JP6104584B2 (ja) 2006-03-15 2012-12-05 チクングンヤウイルスの新規な分離されかつ精製された株、並びにそのポリヌクレオチド及びポリペプチド配列、診断及び免疫原性の使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012266306A Expired - Fee Related JP6104584B2 (ja) 2006-03-15 2012-12-05 チクングンヤウイルスの新規な分離されかつ精製された株、並びにそのポリヌクレオチド及びポリペプチド配列、診断及び免疫原性の使用

Country Status (12)

Country Link
US (2) US20100055105A1 (https=)
EP (2) EP2460822A3 (https=)
JP (2) JP5923232B2 (https=)
AU (1) AU2007226231B2 (https=)
CA (2) CA2545597A1 (https=)
DK (1) DK2001900T3 (https=)
ES (1) ES2543839T3 (https=)
HU (1) HUE025076T2 (https=)
PL (1) PL2001900T3 (https=)
PT (1) PT2001900E (https=)
SI (1) SI2001900T1 (https=)
WO (1) WO2007105111A2 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2545597A1 (en) * 2006-03-15 2007-09-15 Institut Pasteur Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof
CN101516395B (zh) * 2006-09-01 2014-03-26 伯哈拉特生物技术国际有限公司 抗屈曲病毒感染的疫苗
CA2598966A1 (en) * 2007-09-07 2009-03-07 Institut Pasteur Anti-chikungunya monoclonal antibodies and uses thereof
FR2921064A1 (fr) * 2007-09-14 2009-03-20 Biomerieux Sa Oligonucleotides, utilisation, methode de detection et kit permettant de diagnostiquer la presence du gene e1 du virus du chikungunya
CA2720166A1 (en) * 2008-04-04 2009-10-08 David B. Weiner Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same
EP3957754B1 (en) * 2008-04-21 2026-01-28 Gen-Probe Incorporated Method for detecting chikungunya virus
CN102414217A (zh) * 2009-02-25 2012-04-11 彼格泰格私人有限公司 用于检测基孔肯雅病毒的探针和引物
WO2012078116A1 (en) * 2010-12-10 2012-06-14 Agency For Science, Technology And Research Immunogenic chikungunya virus peptides
WO2012131580A1 (en) * 2011-03-28 2012-10-04 Scms, Institute Of Bioscience And Biotechnology Research And Development Method of detecting chikungunya virus utilizing a recombinant el coat peptide antigen
EP2712871A1 (en) * 2012-09-27 2014-04-02 Institut Pasteur Recombinant Measles virus expressing Chikungunya virus polypeptides and their applications
BR112015006840A2 (pt) * 2012-09-27 2017-11-21 Res Found Dev vírus chikungunya atenuado
JP6903120B2 (ja) * 2016-07-15 2021-07-14 エトゥビクス コーポレーション アルファウイルスワクチン接種のための組成物及び方法
TW202300515A (zh) 2016-10-20 2023-01-01 法商賽諾菲公司 抗ｃｈｉｋｖ抗體及其用途
JP7301811B2 (ja) * 2017-09-21 2023-07-03 ヴァルネヴァ エスイー 免疫原性チクングニアウイルスｃｈｉｋｖ－ｄｅｌｔａ ５ｎｓｐ３を含む医薬組成物を製造する方法
WO2020069054A1 (en) * 2018-09-27 2020-04-02 Texas Tech University System Stable cell line secreting chikungunya virus (chikv) virus like particles (vlp) for vaccines
US20230398200A1 (en) * 2020-07-31 2023-12-14 Replicate Bioscience, Inc. Modified chikungunya viruses and sindbis viruses and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100233209A1 (en) * 2005-08-11 2010-09-16 Higgs Stephen T Chikungunya virus infectious clones and uses therefor
CA2545597A1 (en) * 2006-03-15 2007-09-15 Institut Pasteur Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof
CN101516395B (zh) * 2006-09-01 2014-03-26 伯哈拉特生物技术国际有限公司 抗屈曲病毒感染的疫苗

Similar Documents

Publication Publication Date Title
JP2009529868A5 (https=)
CN111218459B (zh) 一种以人复制缺陷腺病毒为载体的重组新型冠状病毒疫苗
AU641211B2 (en) Vaccines
EP3459965B1 (en) Methods of predicting ancestral virus sequences and uses thereof
CN112584849A (zh) 包含核酸及car修饰的免疫细胞的治疗剂及其应用
CN112980852B (zh) 新型冠状病毒b.1.351南非突变株rbd的基因及其应用
CN111926040B (zh) 一种新型冠状病毒rbd核苷酸序列、优化方法与应用
CN114560915B (zh) 一种改造的高滴度SARS-CoV-2假病毒
CN111218477B (zh) 靶向感染哺乳动物细胞的禽4型腺病毒载体及其应用
CN104829732A (zh) 一种重组蛋白及其在昆虫杆状病毒表达系统中的表达方法
CN117683726A (zh) 一种稳定外分泌表达猪流行性腹泻病毒s蛋白的cho细胞系的构建方法
WO2004106360A3 (en) Viral vectors with improved properties
CN113046370B (zh) 新型冠状病毒b．1．1．7英国突变株rbd的基因及其应用
CN113073106B (zh) 新型冠状病毒b.1.525尼日利亚突变株rbd的基因及其应用
CN104059141B (zh) 一种小鼠rankl突变体及其表达载体的构建、表达及应用
Nicholas et al. A 16-amino acid peptide of respiratory syncytial virus 1A protein contains two overlapping T cell-stimulating sites distinguishable by class II MHC restriction elements.
CN106701687B (zh) 一种杂交瘤细胞株及其产生的狂犬病毒磷蛋白单克隆抗体
CN106132986B (zh) TRAIL穿膜肽样突变体MuR5、制备方法及应用
JP5073653B2 (ja) 高レベルのタンパク質を産生する発現ベクター及び方法
CN107034225B (zh) 制备埃博拉病毒糖蛋白与基质蛋白融合突变体的方法
EP4653455A1 (en) Mutated pd1 ectodomain fragment and car containing same, and nk cell
CN113186204B (zh) 新型冠状病毒巴西株p．1突变株rbd的基因及其应用
CN118221829A (zh) 一种il-10单体融合蛋白
CN109706127B (zh) 一种猪圆环病毒2型弱毒株PCV2RmA的构建方法
CN105085638A (zh) KSHV病毒vIRF4 DNA结合域、其多克隆抗体及制备方法